Starting on:
Jul 24, 2026
Ending on:
Jul 24, 2026
Moderator(s):
SERENA HOTEL
Max Credits:
10 Points
Provider:
Arthrheuma Society of Kenya
Claim Points
Jul 24, 2026
Ending on:
Jul 24, 2026
Moderator(s):
Prof.
GEORGE OYOO
PROFESSOR UNIVERSITY OF NAIROBI
Dr. THOMAS MUTIE
Senior Consultant Physician and Gastroenterologist CEO, Consolidated Gastroenterology Clinics
Venue: PROFESSOR UNIVERSITY OF NAIROBI
Dr. THOMAS MUTIE
Senior Consultant Physician and Gastroenterologist CEO, Consolidated Gastroenterology Clinics
SERENA HOTEL
Max Credits:
10 Points
Provider:
Arthrheuma Society of Kenya
Claim Points
JAK Inhibitors in Rheumatology
Starting on:
Jul 24, 2026
Jul 24, 2026
Ending on:
Jul 24, 2026
Jul 24, 2026
Venue:
SERENA HOTEL
SERENA HOTEL
Description
1.JAK Inhibitors in Rheumatology Evidence-based clinical review — mechanisms, applications, and safety 2. What Is the Role of Probiotics in Gastrointestinal Conditions?
Objectives
1. Learning Objectives
* Explain the **JAK–STAT signalling pathway** and how JAK inhibitor selectivity affects clinical outcomes.
* Compare the efficacy of JAK inhibitors across **RA, PsA, axSpA, myositis and SLE** using head-to-head evidence.
* Interpret **MACE, VTE and malignancy risks** from ORAL Surveillance and apply them to individual patients.
* Apply **ACR 2021 and EULAR 2022 recommendations** when selecting and positioning JAK inhibitors after csDMARD failure.
* Use evidence-based **treatment algorithms and clinical cases** to guide therapy decisions.
2. What Is the Role of Probiotics in Gastrointestinal Conditions?
Presenters
-
Dr.
Eugene Kalman
LECTURER UNIVERSITY OF NAIROBI
University Of Nairobi -
Dr.
ERIC MURUNGA
Consultant Gastroenterologist and Hepatologist Gastro & Liver Centre, Nairobi
Gastro & Liver Centre, Nairobi